Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTO-201 for Middle Ear Effusion in Pediatric Subjects
NCT01949142Phase 3Completed
- Sponsor
- Otonomy, Inc.
- Start
- Nov 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of OTO-201 in otitis media with effusion (OME) (2 arms), sponsored by Otonomy, Inc. Primary endpoint: Percentage of Participants Who Were Treatment Failures at Day 15. Started Nov 2013; status: completed.
02
Drugs
OTO-201
03
Conditions
otitis media with effusion (OME)
Beyond the preview
Go deeper on NCT01949142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01949142.